Attorney Erin Copeland to Speak on Essure at Masters of Mass Tort Conference
Partner Erin Copeland of Fibich, Leebron, Copeland & Briggs has been invited to speak at the Masters of Mass Tort legal conference taking place this week. Erin, along with other industry leaders from around the country, will come together to discuss topics unique to mass torts, including currently pending litigation. Erin will be speaking on the Essure® birth control litigation. Erin was recently appointed to the Essure® Plaintiffs’ Executive Committee by Judge Winifred Smith who is presiding over the Essure® JCCP pending in Oakland, Alameda County, California. Erin will share her knowledge and experience concerning the Essure® medical device litigation with other mass tort practitioners who may find themselves representing a client injured by the Essure® product.
Since its approval by the FDA in 2002, the Essure® medical device has been the subject of a number of complaints and adverse event reports to the FDA concerning the risks of personal injury and physical damage to women implanted with the device. The permanent implant is supposed to be incisionless and result in permanent sterilization once implanted into a woman’s fallopian tubes. However, it has been associated with injuries such as chronic pain, abnormally heavy bleeding, migration of the device out of the fallopian tubes, perforation of other organs, and even life threatening ectopic pregnancy to name a few. Many women have even been forced to undergo hysterectomies and other removal surgeries to address the symptoms associated with the Essure® device. Following a 2015 FDA Advisory Committee meeting concerning Essure, the FDA recently required the manufacturer of Essure to add a black box warning to the level to increase awareness of the risks associated with the device.
If you or a loved one has been harmed by Essure® or any other dangerous product or medical device, we encourage you to contact us and discuss your rights with Erin Copeland of Fibich, Leebron, Copeland & Briggs.